FREMONT, Calif., Oct. 29 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Mr. Alnoor Shivji, President and Chief Executive Officer, will deliver a corporate presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The conference will be held November 5 - 7, 2007, at the New York Palace Hotel in New York City.
Mr. Shivji's presentation will take place at 3:20 p.m. EST on Monday, November 5th in the Spellman Room and will be immediately followed by a Q&A session. The presentation will include an overview of the company's SmartChip(TM) product which is currently being developed for the gene expression and genotyping markets, and the SmartSlide(TM) product that WaferGen is actively marketing. A live webcast and 90-day archive of the presentation can be accessed at http://www.wafergen.com.
WaferGen Biosystems Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for gene expression, genotyping, cell biology and stem cell research for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip(TM) is being developed as the first whole genome, high throughput gene expression Real-Time Polymerase Chain Reaction (Real-Time PCR) platform and promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. WaferGen currently markets its SmartSlide(TM) family of products to companies and organizations involved in stem cell and cell biology research. SmartSlide(TM), which was launched in 2006, represents the first fluidics integrated micro-incubators enabling cell biology and stem cell research. Representative SmartSlide(TM) customers include Harvard University, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, Abbott Labs and the National Institutes of Health (NIH).
To learn more about WaferGen, please visit the company's web site at http://www.wafergen.com.
Vida Communication (On behalf of WaferGen)
Stephanie Diaz (investors) Tim Brons (media)
|SOURCE WaferGen Biosystems, Inc.|
Copyright©2007 PR Newswire.
All rights reserved